Late-stage / Active MDL2 activitiesPharmaceutical intelligence

Ozempic NAION

Pharmaceutical · litigation and safety scrutiny around semaglutide products and non-arteritic ant…

DEFENDANT

Pharmaceutical

MDL / TRACK

MDL 3163

E.D. Pa.

JUDGE

Various

PLAINTIFFS

Emerging

BELLWETHER / TRIAL

TBD

SETTLEMENT STATUS

Pending

Case overview Litigation status Geographic exposure Key defendants Timeline Statute of limitations Live activity

Live intelligence

AI litigation brief

Ozempic NAION remains late-stage / active mdl with 2 current signals in the accepted feed.

Overview

PACER court filing on Mar 10: Ozempic NAION: court filing watch. This is the lead item in the current accepted signal set.

Key developments

PACER court filing on Mar 10: Ozempic NAION: court filing watch. openFDA regulatory on Mar 10: Ozempic NAION: FDA regulatory alert.

Trajectory

The feed is being driven by court-side movement, so docket scheduling and case-management orders should lead the next editorial update for Ozempic NAION.

Editorial intelligence

MDL 3163 should stay on the lead docket watch because it is the primary consolidation vehicle for Ozempic NAION.

Generated Mar 10, 2026, 11:39 AM

PACER

Live

Target freshness: within 5 minutes of upstream fetch.

Lag 3 minutes

Last fetch Mar 10, 2026, 11:36 AM

Next fetch Mar 10, 2026, 12:36 PM

Google News

Live

Target freshness: within 5 minutes of upstream fetch.

Lag 4 minutes

Last fetch Mar 10, 2026, 11:35 AM

Next fetch Mar 10, 2026, 12:35 PM

FAERS

Live

Target freshness: within 15 minutes of upstream fetch.

Lag 11 minutes

Last fetch Mar 10, 2026, 11:28 AM

Next fetch Mar 10, 2026, 12:28 PM

PubMed

Live

Target freshness: within 30 minutes of upstream fetch.

Lag 21 minutes

Last fetch Mar 10, 2026, 11:18 AM

Next fetch Mar 10, 2026, 12:18 PM

2 activities detected

⚖️CourtPACER

Detected Mar 10, 2026, 11:34 AM

Ozempic NAION: court filing watch

Federal Courts watchlist initialized for Ozempic NAION. Captions, docket numbers, and venue context are validated before promotion.

AI Litigation Note

PACER court filing on Mar 10 for Ozempic NAION. Ozempic NAION: court filing watch — Federal Courts watchlist initialized for Ozempic NAION. Captions, docket numbers, and venue context are validated before promotion. Monitor docket for scheduling orders, CMOs, and bellwether selections.

Generated Mar 10, 2026, 11:33 AM

Confidence 88%Published Mar 10, 2026, 11:32 AM

View Original Source →

📜RegulatoryFDA

Detected Mar 10, 2026, 11:15 AM

Ozempic NAION: FDA regulatory alert

openFDA monitoring is active for Ozempic NAION. FDA safety alerts, recalls, and enforcement reports are tracked via direct API connection.

AI Litigation Note

openFDA regulatory on Mar 10 for Ozempic NAION. Regulatory developments can change intake posture and motion practice quickly.

Generated Mar 10, 2026, 11:14 AM

Confidence 88%Published Mar 10, 2026, 11:13 AM

LexGenius Ranking

72High Signal

Court, news, and regulatory activity are elevated

Evidence16 / 20

Momentum14 / 20

Exposure14 / 20

Regulatory12 / 20

Legal16 / 20

Monitoring

60 min

refresh interval

Last: Mar 10, 2026, 11:27 AM

Next: Mar 10, 2026, 12:27 PM

Signal feed

activities detected

Google NewsPACERFAERSPubMed

AI Brief

Ozempic NAION remains late-stage / active mdl with 2 current signals in the accepted feed.

Overview

PACER court filing on Mar 10: Ozempic NAION: court filing watch. This is the lead item in the current accepted signal set.

Key developments

PACER court filing on Mar 10: Ozempic NAION: court filing watch. openFDA regulatory on Mar 10: Ozempic NAION: FDA regulatory alert.

Generated Mar 10, 2026, 11:39 AM

Tracked MDLs

MDL 3163

E.D. Pa.

NAION and vision-loss track

← Previous

Ozempic Gastroparesis

Tracks Ozempic gastroparesis and gastrointestinal injury litigation tied to semaglutide products.

Church Abuse

Monitors clergy and church-abuse litigation, legislative action, and accountability reporting across denominations.